中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

43 records (took 0.02 seconds)

    Urea-based mixing process for increasing combustion efficiency and reduction of nitrogen oxides (NOx)
    1.
    发明申请
    Urea-based mixing process for increasing combustion efficiency and reduction of nitrogen oxides (NOx) 有权
    用于提高燃烧效率和减少氮氧化物（NOx）的基于尿素的混合方法

    公开(公告)号：US20070003890A1

    公开(公告)日：2007-01-04

    申请号：US11455924

    申请日：2006-06-19

    Applicant: Brian Higgins

    Inventor： Brian Higgins

    IPC: F23D11/44

    CPC classification number: F23C5/32 ,  F23J7/00 ,  F23L7/002 ,  F23L9/04

    Abstract: A method for reducing NOx formation, including the steps of: providing a furnace with a plurality of secondary air injection ducts, asymmetrically positioned in an opposing manner; injecting fuel with primary air through a first stage prior to injection of a second air; injecting secondary air and aqueous urea solution through the plurality of reagent injection ducts; controlling the asymmetrical injection to produce a high velocity mass flow and a turbulence resulting in dispersion of the urea solution into the combustion space, thereby providing reduced NOx formation in the combustion process.

    Abstract translation: 一种用于减少NOx形成的方法，包括以下步骤：为炉提供多个二次空气喷射管道，以相对的方式不对称地定位; 在注入第二空气之前通过第一阶段向一次空气喷射燃料; 通过所述多个试剂注入管道注入二次空气和尿素水溶液; 控制不对称注入以产生高速质量流和湍流，导致尿素溶液分散到燃烧空间中，从而在燃烧过程中提供减少的NOx形成。

    Combined treatment with cisplatin and an epidermal growth factor receptor kinase inhibitor
    3.
    发明申请
    Combined treatment with cisplatin and an epidermal growth factor receptor kinase inhibitor 有权
    联合治疗顺铂和表皮生长因子受体激酶抑制剂

    公开(公告)号：US20050271747A1

    公开(公告)日：2005-12-08

    申请号：US11145495

    申请日：2005-06-03

    Applicant: Brian Higgins ,  Kenneth Kolinsky

    Inventor： Brian Higgins ,  Kenneth Kolinsky

    IPC: A61K31/4706 ,  A61K31/496 ,  A61K31/517 ,  A61K31/519 ,  A61K31/5377 ,  A61K33/24 ,  A61K38/50

    CPC classification number: A61K31/519 ,  A61K31/4706 ,  A61K31/496 ,  A61K31/517 ,  A61K31/5377 ,  A61K33/24 ,  A61K38/50 ,  A61K2300/00

    Abstract: The present invention provides a method for treating tumors or tumor metastases in a patient, comprising administering to the patient simultaneously or sequentially a therapeutically effective amount of an EGFR kinase inhibitor and cisplatin combination, with or without additional agents or treatments, such as other anti-cancer drugs or radiation therapy. The invention also encompasses a pharmaceutical composition that is comprised of an EGFR kinase inhibitor and cisplatin combination in combination with a pharmaceutically acceptable carrier. A preferred example of an EGFR kinase inhibitor that can be used in practicing this invention is the compound erlotinib HCl (also known as Tarceva™).

    Abstract translation: 本发明提供了一种用于治疗患者的肿瘤或肿瘤转移的方法，其包括向所述患者同时或依次施用治疗有效量的EGFR激酶抑制剂和顺铂组合，所述另外的药物或治疗剂， 癌症药物或放射治疗。 本发明还包括药物组合物，其由EGFR激酶抑制剂和顺铂组合与药学上可接受的载体组合组成。 可用于实施本发明的EGFR激酶抑制剂的优选实例是化合物厄洛替尼HCl（也称为Tarceva TM）。

    Combined treatment with gemcitabine and an epidermal growth factor receptor kinase inhibitor
    6.
    发明申请
    Combined treatment with gemcitabine and an epidermal growth factor receptor kinase inhibitor 审中-公开
    吉西他滨联合治疗和表皮生长因子受体激酶抑制剂

    公开(公告)号：US20050272688A1

    公开(公告)日：2005-12-08

    申请号：US11144952

    申请日：2005-06-03

    Applicant: Brian Higgins ,  Kenneth Kolinsky

    Inventor： Brian Higgins ,  Kenneth Kolinsky

    IPC: A61K31/4706 ,  A61K31/498 ,  A61K31/513 ,  A61K31/517 ,  A61K31/519 ,  A61K31/5377 ,  A61K31/7072

    CPC classification number: A61K31/519 ,  A61K31/4706 ,  A61K31/498 ,  A61K31/513 ,  A61K31/517 ,  A61K31/5377 ,  A61K31/7072 ,  A61K2300/00

    Abstract: The present invention provides a method for treating tumors or tumor metastases in a patient, comprising administering to the patient simultaneously or sequentially a therapeutically effective amount of an EGFR kinase inhibitor and gemcitabine combination, with or without additional agents or treatments, such as other anti-cancer drugs or radiation therapy. The invention also encompasses a pharmaceutical composition that is comprised of an EGFR kinase inhibitor and gemcitabine combination in combination with a pharmaceutically acceptable carrier. A preferred example of an EGFR kinase inhibitor that can be used in practicing this invention is the compound erlotinib HCl (also known as Tarceva™).

    Abstract translation: 本发明提供了一种用于治疗患者的肿瘤或肿瘤转移的方法，其包括向所述患者同时或依次给予治疗有效量的EGFR激酶抑制剂和吉西他滨组合，所述组合具有或不含另外的药物或治疗剂， 癌症药物或放射治疗。 本发明还包括由EGFR激酶抑制剂和吉西他滨组合与药学上可接受的载体组合的药物组合物。 可用于实施本发明的EGFR激酶抑制剂的优选实例是化合物厄洛替尼HCl（也称为Tarceva TM）。

    Method for in-furnace reduction flue gas acidity
    7.
    发明申请
    Method for in-furnace reduction flue gas acidity 有权
    炉内还原烟气酸度的方法

    公开(公告)号：US20050181318A1

    公开(公告)日：2005-08-18

    申请号：US10797513

    申请日：2004-03-10

    Applicant: Brian Higgins

    Inventor： Brian Higgins

    IPC: F23C5/00 ,  F23M3/02

    CPC classification number: F23L9/04 ,  F23C6/047 ,  F23C2201/101 ,  F23C2201/20 ,  F23C2201/30 ,  F23J2215/20

    Abstract: A method for of reducing the acidity and lowering the acid dewpoint of flue gas, the method steps including partially combusting the fuel in a first stage to create a reducing environment; maintaining the reducing environment for a sufficient time period such that reducible acids are reduced to achieve a desirable acidity concentration in the flue gas; and combusting the remainder of the fuel and combustion intermediates in a second stage with oxidizing environment; thereby decreasing the acidity and lowering the acid dewpoint of the flue gas by reducing the acid concentration of the gas.

    Abstract translation: 一种降低烟气酸度和降低酸性露点的方法，所述方法步骤包括在第一阶段部分地燃烧燃料以产生还原环境; 保持还原环境足够的时间，使得可还原的酸被还原以达到烟道气中所需的酸度浓度; 并在具有氧化环境的第二阶段中燃烧剩余的燃料和燃烧中间体; 从而通过降低气体的酸浓度来降低烟气的酸度和降低酸性露点。

    Combustion furnace humidification devices, systems & methods
    8.
    发明申请
    Combustion furnace humidification devices, systems & methods 失效
    燃烧炉加湿装置，系统及方法

    公开(公告)号：US20050013755A1

    公开(公告)日：2005-01-20

    申请号：US10757056

    申请日：2004-01-14

    Applicant: Brian Higgins

    Inventor： Brian Higgins

    IPC: B01D53/56 ,  B01D53/79 ,  F23J7/00 ,  B01D53/34

    CPC classification number: B01D53/79 ,  B01D53/56 ,  B01D2251/206 ,  B01J4/002 ,  B01J19/26 ,  F23J7/00 ,  F23J2215/10 ,  F23J2215/20

    Abstract: An injection device for humidifying a reactor space and injecting and dispersing reagents into the humidified reactor space, including an exterior injection duct for high-velocity gas injection and at least one interior injector for reagent and humidifying agent injection as droplets with a droplet environment. The high-velocity gas ensuring the humidification of the liquid droplet environment and mixing and dispersion of the liquid reagent droplets into the reactor. A multiple injection device system and a method for operating the system are also described.

    Abstract translation: 一种用于加湿反应器空间并将试剂注入并分散到加湿反应器空间中的注射装置，包括用于高速气体注入的外部注入管道和至少一个用于试剂和加湿剂注射的内部注射器，其具有液滴环境的液滴。 高速气体确保液滴环境的加湿，并将液体试剂液滴混合并分散到反应器中。 还描述了多次注射装置系统和操作该系统的方法。

    Memory device with efficient redundancy using sense amplifiers
    9.
    发明授权
    Memory device with efficient redundancy using sense amplifiers 失效
    使用读出放大器高效冗余的存储器件

    公开(公告)号：US5694368A

    公开(公告)日：1997-12-02

    申请号：US751002

    申请日：1996-11-15

    Applicant: Hank H. Lim ,  Brian Higgins

    Inventor： Hank H. Lim ,  Brian Higgins

    IPC: G11C7/06 ,  G11C7/10 ,  G11C11/4091 ,  G11C29/00 ,  G11C13/00

    CPC classification number: G11C29/848 ,  G11C11/4091 ,  G11C7/06 ,  G11C7/10

    Abstract: A memory device is described which has memory storage cells coupled to data bit lines. Sense amplifier circuits are provided to receive input from the data bit lines and produce an output in response thereto. The memory includes circuitry which shifts the input to the sense amplifiers. Data bit lines from a neighboring sense amplifier is shifted to another sense amplifier such that redundant memory storage cells and data bit lines can be substituted for defective ones.

    Abstract translation: 描述了具有耦合到数据位线的存储器存储单元的存储器件。 提供感测放大器电路以从数据位线接收输入并响应于此产生输出。 存储器包括将输入移位到读出放大器的电路。 来自相邻读出放大器的数据位线被移位到另一个读出放大器，使得可以用冗余存储器存储单元和数据位线代替有缺陷的存储单元。

    Expert system for providing interactive assistance in solving problems such as health care management
    10.
    发明授权
    Expert system for providing interactive assistance in solving problems such as health care management 失效
    专家系统，提供互动帮助，解决医疗保健管理等问题

    公开(公告)号：US5517405A

    公开(公告)日：1996-05-14

    申请号：US136649

    申请日：1993-10-14

    Applicant: Peter D. McAndrew ,  David L. Potash ,  Brian Higgins ,  Jeff Wayand ,  Joe Held

    Inventor： Peter D. McAndrew ,  David L. Potash ,  Brian Higgins ,  Jeff Wayand ,  Joe Held

    IPC: G06F19/00 ,  G09B7/04 ,  G06F159/00 ,  G06F17/60

    CPC classification number: G09B7/04 ,  G06F19/345 ,  G06F19/363 ,  G06Q50/22 ,  G06F19/325 ,  G06F19/3487 ,  Y10S706/924

    Abstract: A problem solving expert system is provided which is particularly useful in managing the health care of individual patients. A description of a problem (e.g., medical condition) and a proposed solution therefor (e.g., medical procedure) is entered via a user interface. A topical library is searched to identify information relevant to the problem and proposed solution. Access to the identified information is available in either a full text or synopsis format, to assist a user in assessing the appropriateness of the proposed solution. An inference engine provides a recommendation to the user as to the appropriateness of the proposed solution based on information entered via the user interface and rules associated with the inference engine. A user can interact with the inference engine in either a structured or guided mode. The structured mode is directed to inexperienced users and dynamically generates questions in response to previous answers provided by the user to enable the inference engine to make its recommendation. The guided mode is directed to experienced users and provides a predefined questionnaire enabling the user to decide which questions to answer in order to obtain a recommendation.

    Abstract translation: 提供了一个解决问题的专家系统，在管理个体患者的医疗保健方面特别有用。 通过用户界面输入问题的描述（例如，医疗条件）及其提出的解决方案（例如医疗程序）。 搜索一个专题图书馆来识别与问题相关的信息和提出的解决方案。 访问所标识的信息可以以全文或简要格式提供，以帮助用户评估拟议解决方案的适用性。 推理引擎基于通过用户界面输入的信息和与推理机相关联的规则向用户提供关于所提出的解决方案的适当性的建议。 用户可以以结构化或引导模式与推理机进行交互。 结构化模式针对无经验的用户，并响应于用户提供的先前答案动态地产生问题，以使推理机能够推荐。 指导模式针对有经验的用户，并提供预定义的问卷，使用户能够决定要回答哪些问题以获得建议。

Patent Agency Ranking